- Corporate Officers - W
- Wengel Kathryn E
Insider Trading History of Wengel Kathryn E
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wengel Kathryn E since 2019.
This trader's CIK number is 1745955.
At the time of last reporting, Wengel Kathryn E was the EVP, Chief TO and Risk Officer of Johnson & Johnson. (stock ticker symbol JNJ).
Also see all insider trading activities at Johnson & Johnson.
Note that in the past
Wengel Kathryn E also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Johnson & Johnson (JNJ) by Wengel Kathryn E
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | JNJ | 0 | $0 | 0 | $0 | 32,762 | $3,278,165 |
2024 | JNJ | 0 | $0 | 0 | $0 | 52,073 | $3,223,100 |
2023 | JNJ | 0 | $0 | 12,465 | $1,994,400 | 1,807 | $0 |
2022 | JNJ | 0 | $0 | 56,410 | $9,765,812 | 68,692 | $4,091,981 |
2021 | JNJ | 0 | $0 | 0 | $0 | 10,362 | $0 |
2020 | JNJ | 0 | $0 | 16,115 | $2,473,926 | 31,924 | $1,027,895 |
2019 | JNJ | 0 | $0 | 2,017 | $284,538 | 14,621 | $126,304 |
Yearly summary of insider trading at Labcorp Holdings Inc. (LH) by Wengel Kathryn E
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | LH | 0 | $0 | 0 | $0 | 944 | $0 |
2024 | LH | 0 | $0 | 0 | $0 | 947 | $0 |
2023 | LH | 0 | $0 | 0 | $0 | 742 | $0 |
2022 | LH | 0 | $0 | 0 | $0 | 603 | $0 |
Insider trading activities at 2 companies by Wengel Kathryn E:
1. Johnson & Johnson (JNJ)
2. Labcorp Holdings Inc. (LH)
Table 1. Insider trading of Johnson & Johnson (JNJ) by Wengel Kathryn E
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-02-07 | JNJ | Option Ex | 32,762 | 100.06 | 3,278,165 |
2024-02-13 | JNJ | Option Ex | 651 | .00 | 0 |
2024-02-12 | JNJ | Option Ex | 13,813 | .00 | 0 |
2024-02-09 | JNJ | Option Ex | 35,638 | 90.44 | 3,223,100 |
2024-02-08 | JNJ | Option Ex | 1,971 | .00 | 0 |
2023-06-12 | JNJ | Sale | 12,465 | 160.00 | 1,994,400 |
2023-02-10 | JNJ | Option Ex | 1,807 | .00 | 0 |
2022-11-09 | JNJ | Option Ex | 16,410 | 72.54 | 1,190,381 |
2022-11-09 | JNJ | Sale | 16,410 | 173.42 | 2,845,772 |
2022-06-10 | JNJ | Option Ex | 40,000 | 72.54 | 2,901,600 |
2022-06-10 | JNJ | Sale | 40,000 | 173.00 | 6,920,040 |
2022-02-15 | JNJ | Option Ex | 10,386 | .00 | 0 |
2022-02-14 | JNJ | Option Ex | 1,896 | .00 | 0 |
2021-02-12 | JNJ | Option Ex | 10,362 | .00 | 0 |
2020-09-02 | JNJ | Sale | 16,115 | 153.52 | 2,473,926 |
2020-09-02 | JNJ | Option Ex | 16,115 | 63.78 | 1,027,895 |
2020-02-13 | JNJ | Option Ex | 15,809 | .00 | 0 |
2019-12-12 | JNJ | Option Ex | 2,017 | 62.62 | 126,304 |
2019-12-12 | JNJ | Sale | 2,017 | 141.07 | 284,538 |
2019-02-08 | JNJ | Option Ex | 5,882 | .00 | 0 |
2019-02-11 | JNJ | Option Ex | 6,722 | .00 | 0 |
Table 2. Insider trading of Labcorp Holdings Inc. (LH) by Wengel Kathryn E
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-02-06 | LH | Option Ex | 944 | .00 | 0 |
2024-02-07 | LH | Option Ex | 947 | .00 | 0 |
2023-02-11 | LH | Option Ex | 742 | .00 | 0 |
2022-03-25 | LH | Option Ex | 603 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Wengel Kathryn E
(EVP, Chief TO and Risk Officer of Johnson & Johnson at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.